Uppsala University
Uppsala, 75319, Sweden
NCT Number: NCT01815203
With the abundance of energy-dense foods that are designed for ease of consumption in the current environment, it is of importance to better understand the factors that may undermine the control of energy intake at healthy levels.
One of the factors that is potentially important in response inhibition is caffeine.
The aim is to assess the direct effects of caffeine on response inhibition, using a No Go/Go-task. We will also assess whether the presentation of food cues, i.e. as words or as pictures, modulate response inhibition different in restrained vs. non-restrained eaters.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Uppsala, 75319, Sweden
In a blinded, randomized cross-over design, participants will receive either a capsule with caffeine or placebo at two separate occasions whereupon study tasks will be performed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of one gelatin capsule containing 200-300 mg of caffeine with subsequent cognitive tasks and food test.
Administration of placebo with subsequent cognitive tasks and food test.
Time frame: 20 min
Measurement inhibition control via a computer test (NoGo-Go task.
Time frame: 20 min
Measure of participants food intake.
Time frame: 5 min (1 sample)
Blood glucose assessment in order to confirm fasted condition prior to study experiments.
Uppsala University
Other
Does Caffeine Consumption Improve Response Inhibition to Food Cues?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07611201
Anosmia, Appetite
West Lafayette, Indiana, United States
View Trial DetailsNCT04847843
Bariatric Surgery Candidate, Behavior
Salt Lake City, Utah, United States
View Trial DetailsNCT06829862
Behavior, Behavior, Animal
Valencia, Valencia-valència, Spain
View Trial DetailsNCT06087185
Anxiety, Anxiety Disorders
Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details